LDS/Medical Tests/Extractable Nuclear Antigen Antibody Panel (Autoantibodies in Connective Tissue Diseases)

Extractable Nuclear Antigen Antibody Panel (Autoantibodies in Connective Tissue Diseases)

Connective diseases are systemic autoimmune diseases which are, most often, selectively directed against a specific organ. In these diseases, autoantibodies are developed against the patient's own tissue and own cell components for unknown reasons. This triggers an immune response and in some the response can be so strong that it results in tissue damage. Although damage is caused by the autoantibody, the immune response from most of these antibodies are predominately non-organ specific. Antinuclear Antibody, Rheumatoid Factor, and Collagen Antibodies are a few examples. The influencing factors for autoantibody development include genetics, age and exogenous factors. Exacerbations and remissions often occur, as the disease is not always a progressive one. Hormonal influences such as estrogen are believed to play a developing part in some autoantibody diseases such as SLE. Among automimmune antibodies causing connective tissue diseases are anti-nuclear antibodies, which often appear in the patient’s serum before any definite symptomatic sign. Testing for these antibodies allows the identification of the specific connective disease. The quantity of some of these autoantibodies, in particular the anti-dsDNA, provides vital information on progression of the disease and for monitoring treatment. Other known antibodies are Anti-SSA and anti-SSB antibodies. Either one or both of these are observed in connective tissue diseases such as Sjögren’s syndrome and Systemic Lupus Erythematosus. Other known autoantibodies are Anti-RNP antibodies. These antibodies are found primarily in Mixed Connective Tissue Disease. They are also observed in SLE but in lower titer. Anti-Sm antibodies are another antibody found in SLE and some other autoimmune diseases. Anti-ribosomal antibodies are strongly associated with central neurological abnormalities in Lupus and Anti-Scl70 antibodies are specific for diffuse Scleroderma. Anti-Jo1 antibodies are found exclusively in sera from patients suffering from Polymyositis and Anti-Centromere antibodies are most often found in sera from patients with CREST syndrome. Cyclic citrullinated peptide (CCP) antibodies are strongly associated with rheumatoid arthritis. For more on autoantibodies and related diseases see table below.

AutoantibodyAssociated DiseaseFrequency in patients with diseaseIFA Pattern
SSA (Ro)SLE, Sjögren’s syndrome, neonatal lupus~25-35% SLE ~40-70% Sjögren’s syndrome ~100% neonatal LupusFine speckles
SSB (La)Sjögren’s Syndrome, SLE~30% in Sjögren’s ~10% in SLEFine Speckles
SmSLE (Highly specific)~15-30% in SLECoarse speckles
RNPMixed Connective Tissue Disease (sclerodactily, Raynaud’s phenomenon, esophageal dysmotility)~95% MCTD ~20% Systemic Sclerosis ~38% SLELarge, coarse speckles Cytoplasmic RNP – dense cytoplasmic often accompanied by homogenous nucleolar
Scl-70Scleroderma~20 - 35% SclerodermaGranular nucleolar, homogenous nucleoplasmic & chromatin in metaphase
Jo-1Polymyositis~20 -40% PolymyositisSpeckled cytoplasm is observed in ~30%
CentromereScleroderma CREST variant (Calcinosis, Raynaud’s, Esophageal dysmotility, sclerodactily, and telangiectasia)~80% limited systemic sclerosis ~15% Systemic sclerosisDiscrete speckled, centromere in metaphase
  • Diagnosis of Systemic Lupus Erythematosus
  • Diagnosis of Rheumatoid Arthritis
  • Diagnosis of Scleroderma
  • Diagnosis of Polymyositis
  • Diagnosis of Dermatomyositis
  • As an aid in diagnosis of Sjögren syndrome
  • As an aid in evaluation of CREST syndrome
  • As an aid in evaluation of vaculitis
  • Aid in diagnosis of Mixed Connective Tissue Disease

Increased in:

  • Systemic Lupus Erythematosus
  • Inflammatory myopathies, some
  • Sjögren syndrome
  • Scleroderma
  • Rheumatoid Arthritis
  • Polymositis
  • Dermatomyositits
  • Mixed Connective Tissue Disease
  • CREST syndrome
  • Vasculitis, some
  • Paraneoplastic syndrome,some
  • Endocarditis, some
  • Fibromyalgia
  • Chronic Fatigue syndrome
  • Sarcoidosis
  • Nephrotic syndrome
  • Acute Poststreptococcal Glomerulonephritis

Negative (No antibody detected)

 

 

Enzyme Linked Immunosorbent Assay, Indirect Fluorescent Antibody.

Serum (SST). 

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Complete Blood Count, ESR, C-Reactive Protein, Extractible Nuclear Antigen Antibodies, Double Stranded DNA Antibody, Antiphospholipid Antibody, Lupus anticoagulant activity, ANA by IFA, ANCA, anti-histones, Urinalaysis, Compliment profile, Immune complexes, Rheumatoid factor, Anti-thyroglobulin antibody, Renal function studies.

3-5 days. 

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Clin Exp Rheumatol. 1997 Jul-Aug;15(4):457-65. [PMID: 9272315]
  • Autoimmun Rev. 2007 Jun;6(6):334-40. [PMID: 17537377]
  • Biomed Pharmacother. 2006 Dec;60(10):648-55. [PMID: 17064873]
  • Clin Rheumatol. 1990 Mar;9(1 Suppl 1):100-10. [PMID: 2203588]
  • Mayo Clin Proc. 1995 Feb;70(2):183-4. [PMID: 7845044]
  • Turgeon, Mary L., 1990. Immunology and serology in laboratory medicine. The C.V. Mosby Company. St. Louis, Missouri.